---
title: "Is NMN a drug? FDA status and NR safety | HealthRX.com"
description: "Human trial safety data for NMN and NR, plus FDA's 2022 position on NMN and its 2025 reversal, and what is still unknown about long-term use."
url: https://healthrx.com/nad-nmn/safety-signals-fda
publisher: HealthRX.com
---


HealthRX.com

FDA reversed its NMN stance, but safety data remain small

[Print or save as PDF](https://healthrx.com/printables/nad-nmn/safety-signals-fda?print=1)

Key numbers

- 1,250 mg NMN dose taken once daily for up to 4 weeks in a 31-adult safety study with no severe adverse events Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/36002548/), as cited Nov 8, 2026
- 3,000 mg/day NR dose in the Parkinson's NR-SAFE trial, with no moderate or severe adverse events over 4 weeks Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/38016950/), as cited Nov 8, 2026
- 500 mg twice daily NR dose in a 2 x 6-week crossover trial in healthy middle-aged and older adults that was well tolerated Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/29599478/), as cited Nov 8, 2026
- 250 mg/day NMN dose for 12 weeks in 30 healthy adults with no abnormalities or obvious adverse effects Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35479740/), as cited Nov 8, 2026

[See the public record for NMN (nicotinamide mononucleotide)](https://healthrx.com/data/nmn-nicotinamide-mononucleotide)

HealthRX.com quick answer. In short, small human trials, NMN and NR produced no serious or severe adverse events at the doses studied, but neither is an FDA-approved drug [1][2]. FDA's 2022 position that NMN could not be sold as a dietary supplement was reversed: its response to a citizen petition, dated September 29, 2025, treats NMN as lawful in supplements, subject to new-dietary-ingredient notification rules [1]. In a 31-person study, NMN 1,250 mg once daily for up to 4 weeks produced no severe adverse events; in a 20-person Parkinson's disease trial, NR 3,000 mg daily for 4 weeks produced no moderate or severe adverse events [3][4].

At a glance

- FDA status, NMN / Lawful supplement ingredient after FDA's 2025 petition response; NDI notification still required [1]
- FDA status, NR / FDA had 'no questions' on a 2016 GRAS notice; not an approval [5]
- NMN dose in the 4-week safety study / 1,250 mg once daily for up to 4 weeks in 31 adults [3]
- NR dose in the Parkinson's safety trial / 3,000 mg daily for 4 weeks in 20 people [4]
- NR tolerability / Well tolerated and raised NAD+ metabolism in a randomized crossover trial of healthy middle-aged and older adults [6]
- Longest dosing in the trials described / 12 weeks [8][13]
- Drug interactions / A PubMed search found no human interaction studies [2]

## What has FDA actually done about NMN?

FDA first raised the question in late 2022, when it told two NMN ingredient makers, SyncoZymes and Inner Mongolia Kingdomway, that NMN could not be marketed as a dietary supplement [7]. The stated reason was the drug-exclusion clause of the Food, Drug, and Cosmetic Act, section 201(ff)(3)(B): NMN had been authorized for investigation as a new drug (MIB-626, Metro International Biotech) before it was marketed as a supplement [7]. Those 2022 letters are known from trade press reports [7].

Next came the petition. The Natural Products Association and the Alliance for Natural Health USA filed a citizen petition in March 2023 (docket FDA-2023-P-0872, posted March 9, 2023), and FDA sent an interim 'no decision yet' response on August 30, 2023 [7].

Then the reversal. On September 29, 2025, FDA's Human Foods Program posted its response letter in that docket, recorded as a 'Partial Petition Approval and Denial'. Reports of the letter say FDA concluded that NMN is not excluded from the dietary supplement definition, because it found evidence NMN was marketed as a supplement in the US before it was authorized for drug investigation [1].

What followed is less firm. Trade press reported follow-up letters dated December 2, 2025 to the two ingredient makers, saying FDA had reconsidered and no longer treats NMN as excluded; the SyncoZymes letter reportedly reinstated a May 2022 'no objection' response to that company's NDI notification. The Natural Products Association's lawsuit against FDA, filed in August 2024 and stayed while FDA considered the petition, was reported dismissed without prejudice on December 29, 2025 [7]. Those last two steps are trade-press reports and were not confirmed on fda.gov [7].

Questions worth asking

Choose the questions you want to keep Is it legal for me to buy NMN as a supplement in the US right now? What does GRAS status mean, and how does it apply to NR compared with NMN? Are the NMN and NR safety trials long enough to rule out long-term harm? How can I check whether an NMN product is pure and contains what its label claims? Should I tell my doctor or pharmacist about NMN or NR before starting a prescription medicine?

## Is NMN banned in the US?

No. NMN is sold in the US as an oral dietary supplement, and after the 2025 petition response FDA treats it as lawful in supplements [1]. It remains a new dietary ingredient, so a maker must file an NDI notification, or rely on a prior notification covering that supplier's ingredient, before selling it [1]. Reports of FDA's letter say it did not define what counts as 'substantial clinical investigations' [1].

What NMN is not: an approved drug. Neither NMN nor NR is FDA-approved, and no NAD+ precursor product is approved to treat aging or any disease [1].

What people on Reddit report

Reddit users discussing whether NMN and NR are legal to sell, whether retailers will resume sales, and how the FDA's regulatory status compares between the two ingredients.

TempusCrystallum · NicotinamideRiboside

It's similar in the US where NR has GRAS (generally recognized as safe) status from the FDA, but NMN doesn't. This doesn't necessarily mean NMN isn't safe though.

A commenter notes that NR holds GRAS status with the FDA while NMN does not, and argues that this alone does not mean NMN is unsafe.

[Read the source discussion](https://www.reddit.com/r/NicotinamideRiboside/comments/s2ypf1/is_nmn_safe_for_human_consumption_in_eu/)

Joe-Cannon · Supplements

My hunch is it won't be banned. From what I saw it sounds like the industry makes a good argument

A commenter who followed the earlier ban debate expects NMN will not be banned, based on the industry's arguments.

[Read the source discussion](https://www.reddit.com/r/Supplements/comments/11mdsjo/nmn_ban_update/)

FlummoxedXer · NMN

Any indications if Amazon or other retailers are now lifting their NMN bans?

A commenter asks whether large retailers have reversed their earlier removal of NMN products after the FDA's position changed.

[Read the source discussion](https://www.reddit.com/r/NMN/comments/1ntwlja/fda_caves_declares_nmn_lawful_in_dietary/)

## What has FDA said about NR?

In 2016 FDA answered a GRAS notice filed on behalf of ChromaDex for nicotinamide riboside chloride (GRN 000635) with a 'no questions at this time' letter dated August 3, 2016, and stated that it had not made its own GRAS determination [5]. That is a response to a company's own safety conclusion, not an approval, and not an endorsement of NR for any use [5].

The notice itself covered NR as a source of vitamin B3 in vitamin waters, protein shakes, nutrition bars, gum, chews and powdered beverages, at a maximum of 0.0057% by weight as consumed, and stated it was not intended for foods for infants and toddlers [5].

## What the human safety trials show for NMN

One repeated-dose NMN safety study gave 1,250 mg once daily for up to 4 weeks to 31 healthy adults aged 20 to 65 in a randomized, double-blind, placebo-controlled design. There were no severe adverse events and no changes beyond normal physiological variation in body measurements, hematology, biochemistry, urine or body composition [3].

At lower doses over longer periods: 250 mg/day for 12 weeks in 30 healthy adults produced no abnormalities on physiological or laboratory testing and no obvious adverse effects [8]. In a dose-ranging trial, 80 healthy middle-aged adults took 300, 600 or 900 mg daily for 60 days with no safety issues on adverse-event, laboratory and clinical monitoring [9]. A 6- or 12-week trial of 250 mg/day in healthy older men reported that NMN was well tolerated with no significant deleterious effect [10].

Single doses of 100, 250 and 500 mg in 10 healthy men caused no significant clinical symptoms and no significant change in heart rate, blood pressure, oxygen saturation or body temperature; serum bilirubin rose and serum creatinine, chloride and blood glucose fell, all within normal ranges and independent of dose [11]. In a 10-week trial of NMN 250 mg/day in 25 postmenopausal women with [prediabetes](https://healthrx.com/conditions-prediabetes/diagnosis-algorithm) who were overweight or obese, no adverse events were reported, and insulin-stimulated glucose disposal rose in the NMN group but not the placebo group [12].

## What the human safety trials show for NR

A 2 x 6-week randomized crossover trial (NR 500 mg twice daily) found that NR was well tolerated and increased NAD+ metabolism in healthy middle-aged and [older adults](https://healthrx.com/nad-nmn/older-adult-dosing) [6]. It recorded 14 mild adverse events in 7 participants (nausea, flushing, leg cramps, bruising) and no serious events [6].

At higher doses and in different populations: NR 1,000 mg twice daily (2,000 mg/day) for 12 weeks in 40 sedentary obese men caused no serious adverse events and safety blood tests were normal [13]. In the NR-SAFE trial, 20 people with Parkinson's disease took NR 1,500 mg twice daily (3,000 mg/day) or placebo for 4 weeks with no moderate or severe adverse events and no significant difference in mild adverse events [4]. A phase I trial of NR 1,000 mg daily for 30 days in 30 newly diagnosed, untreated Parkinson's patients was well tolerated [14].

In a 21-day randomized crossover trial in 12 men aged 70 to 80, NR 1 g/day did not raise muscle NAD+ (210 vs 197 pmol/mg, p=0.22), although a marker of NAD+ synthesis doubled; mitochondrial respiration, [grip strength](https://healthrx.com/labs-grip-strength/what-it-measures), insulin sensitivity and muscle blood flow were unchanged [15]. No clinical adverse events were reported, and four of the 12 men (33%) self-reported increased libido on NR versus none on placebo [15].

## Methylation and homocysteine signals

In the 21-day study of 12 older men, NR 1 g/day raised nicotinamide-methylation products about 5-fold in muscle, indicating clearance of excess nicotinamide through methylation [15].

In NR-SAFE, NR recipients had a slight initial rise in serum [homocysteine](https://healthrx.com/labs-homocysteine/what-it-measures), but the authors judged the methyl donor pool to be intact [4].

## Does boosting NAD+ raise cancer risk?

This is a theoretical concern, not an observed one. Cancer risk with chronic NAD+ boosting has been raised as a theoretical concern, and no human data were identified [2].

## Who has not been studied, and the long-term gap

Trials were short and small, and long-term human safety is not established [2]. Pregnancy, breastfeeding, children, and people with cancer or kidney or [liver disease](https://healthrx.com/nad-nmn/hepatic-impairment) were not studied in the cited trials, so safety in these groups is unknown [2].

## Is there evidence of drug interactions with NMN or NR?

A PubMed search found no human [drug-interaction](https://healthrx.com/nad-nmn/drug-drug-interactions) study of NMN or NR covering CYP enzymes, drug transporters or pharmacodynamic effects [2]. With no such studies, there is no basis for saying either compound is safe alongside a specific drug, or that it interacts with one.

One Parkinson's-specific note: in NR-SAFE, an apparent improvement in MDS-UPDRS scores was also associated with a shorter interval since the last levodopa dose, so the clinical result is confounded [4].

## Is injectable or IV NAD+ FDA-approved?

No. Injected or IV NAD+ is a compounded product, not an FDA-approved drug, and no NAD+ drug is approved for aging or wellness [16]. This page does not state a compounding category for NAD+.

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the article, is NMN banned in the US?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Printable supplement log

NMN and NR supplement log and questions for your pharmacist

Use this sheet if you take or are considering NMN or NR supplements. Record the product details, bring your questions and medicine list to a prescriber or pharmacist, and track any changes you notice over time.

[Open the fill-in sheet](https://healthrx.com/printables/nad-nmn/safety-signals-fda) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Is NMN banned in the United States?

No. FDA took the position in late 2022 that NMN was excluded from the dietary supplement definition, but its response to a citizen petition dated September 29, 2025 concluded that NMN is not excluded, because it found evidence NMN was marketed as a supplement before it was authorized for drug investigation [1]. NMN is still a new dietary ingredient, so a maker must file an NDI notification or rely on a prior notification covering that supplier's ingredient [1].

Has FDA approved NMN or NR for anything?

Neither is an FDA-approved drug, and no NAD+ precursor product is approved to treat aging or any disease [1]. For NR, FDA answered a 2016 GRAS notice for nicotinamide riboside chloride with a no-questions letter and stated that it had not made its own GRAS determination [5].

What side effects were reported in the trials?

The trials described reported no serious or severe events at the doses tested. In a randomized NR crossover trial in healthy middle-aged and older adults, 14 mild events (nausea, flushing, leg cramps, bruising) occurred in 7 participants [6]. NMN 1,250 mg once daily for up to 4 weeks in 31 adults produced no severe adverse events and no changes beyond normal physiological variation [3].

How long were the safety studies?

Durations ranged from single doses to 12 weeks in the trials described, for example 4 weeks for NMN 1,250 mg/day [3], 60 days for NMN 300 to 900 mg/day [9] and 12 weeks for NMN 250 mg/day [8] and NR 2,000 mg/day [13].

Do NMN or NR interact with prescription medications?

A PubMed search found no human drug-interaction studies of NMN or NR covering CYP enzymes, transporters or pharmacodynamic effects [2]. Without such studies, nothing specific can be said about combining either compound with a given drug.

What NMN dose was used in the 4-week safety study?

1,250 mg once daily for up to 4 weeks, in a randomized, double-blind, placebo-controlled study of 31 healthy adults aged 20 to 65, with no severe adverse events [3]. It was a safety evaluation and does not establish a recommended dose [3].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

Why did the FDA pull NMN off the market?

FDA did not keep NMN off the market. In late 2022 it said NMN could not be sold as a dietary supplement because it had been authorized for drug investigation first. Its September 29, 2025 response to a citizen petition reversed that and treats NMN as lawful in supplements, though it remains a new dietary ingredient that requires an NDI notification. Some later follow-up steps were reported only by trade press and were not confirmed on fda.gov.

Did the FDA approve the NMN supplement?

No. Neither NMN nor NR is FDA-approved as a drug, and no NAD+ precursor product is approved to treat aging or any disease. For NR, FDA only responded to a 2016 GRAS notice from ChromaDex with a 'no questions at this time' letter and stated that it had not made its own GRAS determination, which is not an approval.

References

Show all 19 references Hide references

1. FDA Human Foods Program. Response letter to citizen petition, docket FDA-2023-P-0872 (posted September 29, 2025). Regulations.gov. [FDA-2023-P-0872-2754](https://www.regulations.gov/document/FDA-2023-P-0872-2754)
2. Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH. [Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions](https://pubmed.ncbi.nlm.nih.gov/37068054/). J Gerontol A Biol Sci Med Sci. 2023;78(12):2435-2448.
3. Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T. [Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women](https://pubmed.ncbi.nlm.nih.gov/36002548/). Sci Rep. 2022;12(1):14442.
4. Berven H, Kverneng S, Sheard E, Søgnen M, Af Geijerstam SA, Haugarvoll K, et al. [NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/38016950/). Nat Commun. 2023;14(1):7793.
5. [Agency Response Letter GRAS Notice No. GRN 000635 | FDA](https://www.fda.gov/food/gras-notice-inventory/agency-response-letter-gras-notice-no-grn-000635).
6. Martens CR, Denman BA, Mazzo MR, Armstrong ML, Reisdorph N, McQueen MB, et al. [Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults](https://pubmed.ncbi.nlm.nih.gov/29599478/). Nat Commun. 2018;9(1):1286.
7. FDA docket FDA-2023-P-0872, citizen petition on NMN as a dietary ingredient. Regulations.gov. [FDA-2023-P-0872 docket](https://www.regulations.gov/docket/FDA-2023-P-0872)
8. Okabe K, Yaku K, Uchida Y, Fukamizu Y, Sato T, Sakurai T, et al. [Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects](https://pubmed.ncbi.nlm.nih.gov/35479740/). Front Nutr. 2022;9:868640.
9. Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, et al. [The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial](https://pubmed.ncbi.nlm.nih.gov/36482258/). Geroscience. 2023;45(1):29-43.
10. Igarashi M, Nakagawa-Nagahama Y, Miura M, Kashiwabara K, Yaku K, Sawada M, et al. [Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men](https://pubmed.ncbi.nlm.nih.gov/35927255/). NPJ Aging. 2022;8(1):5.
11. Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, et al. [Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men](https://pubmed.ncbi.nlm.nih.gov/31685720/). Endocr J. 2020;67(2):153-160.
12. Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. [Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women](https://pubmed.ncbi.nlm.nih.gov/33888596/). Science. 2021;372(6547):1224-1229.
13. Dollerup OL, Christensen B, Svart M, Schmidt MS, Sulek K, Ringgaard S, et al. [A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects](https://pubmed.ncbi.nlm.nih.gov/29992272/). Am J Clin Nutr. 2018;108(2):343-353.
14. Brakedal B, Dölle C, Riemer F, Ma Y, Nido GS, Skeie GO, et al. [The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/35235774/). Cell Metab. 2022;34(3):396-407.e6.
15. Elhassan YS, Kluckova K, Fletcher RS, Schmidt MS, Garten A, Doig CL, et al. [Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures](https://pubmed.ncbi.nlm.nih.gov/31412242/). Cell Rep. 2019;28(7):1717-1728.e6.
16. FDA. Bulk drug substances used in compounding. [FDA compounding page](https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503a-fdc-act)
17. Reddit participants. [is NMN safe for human consumption in eu? (r/NicotinamideRiboside)](https://www.reddit.com/r/NicotinamideRiboside/comments/s2ypf1/is_nmn_safe_for_human_consumption_in_eu/). Accessed 2026-11-10.
18. Reddit participants. [NMN Ban Update (r/Supplements)](https://www.reddit.com/r/Supplements/comments/11mdsjo/nmn_ban_update/). Accessed 2026-11-10.
19. Reddit participants. [FDA caves - Declares NMN lawful in dietary supplements (r/NMN)](https://www.reddit.com/r/NMN/comments/1ntwlja/fda_caves_declares_nmn_lawful_in_dietary/). Accessed 2026-11-10.

Next in this cluster

Related reading

- [nicotinamide mononucleotide CoQ10 with NMN](https://healthrx.com/supplements-nad-nmn/with-coq10)
- [nicotinamide mononucleotide NMN calcium interaction](https://healthrx.com/supplements-nad-nmn/with-calcium)
- [nicotinamide mononucleotide NMN caffeine](https://healthrx.com/supplements-nad-nmn/with-caffeine)
- [nicotinamide mononucleotide NMN FDA status](https://healthrx.com/regulatory-nad-nmn/compounding-status)
- [nicotinamide mononucleotide NMN self injection](https://healthrx.com/nad-nmn/self-injection-technique)
- [nicotinamide mononucleotide NMN sexual function](https://healthrx.com/nad-nmn/sexual-function-impact)
- [nicotinamide mononucleotide NMN special populations](https://healthrx.com/nad-nmn/special-populations)
- [nicotinamide mononucleotide NMN storage](https://healthrx.com/nad-nmn/storage-stability)
- [nicotinamide mononucleotide NMN switching protocol](https://healthrx.com/nad-nmn/switching-protocols)
- [nicotinamide mononucleotide UnitedHealthcare NMN coverage](https://healthrx.com/nad-nmn/unitedhealthcare-coverage)
- [nicotinamide mononucleotide NMN dosing young adult](https://healthrx.com/nad-nmn/young-adult-dosing)
- [nicotinamide mononucleotide NMN monitoring young adult](https://healthrx.com/nad-nmn/young-adult-monitoring)
- [nicotinamide mononucleotide NMN metformin interaction](https://healthrx.com/interactions-nad-nmn/with-metformin)
- [nicotinamide mononucleotide Can You Take NMN or NR with Warfarin? Drug Interaction Guide](https://healthrx.com/interactions-nad-nmn/with-warfarin)

![NMN NR safety signals FDA: shopper examining an unlabeled supplement bottle in a store aisle](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/nad-nmn/safety-signals-fda.webp)

Shoppers face shifting FDA positions on NMN, so checking a supplement's regulatory status matters before buying. Full NMN safety guide and sources at [healthrx.com/nad-nmn](https://healthrx.com/nad-nmn).

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
